DaShenLin Pharmaceutical Group Co Ltd. Stock Analysis 603233.SS

DaShenLin Pharmaceutical Group Co., Ltd. engages in the chain retail business of medicines, chinese herbal medicine slices, ginseng and antler tonics, health products, medical devices, personal care products, household products. The company is headquartered in Guangzhou, Guangdong and currently employs 41,141 full-time employees. The company went IPO on 2017-07-31. The firm is mainly engaged in the chain retail business of Chinese and Western patent medicines, ginseng and antler tonic medicinal materials and Chinese herbal medicine slices, health products, medical devices and other commodities. The firm is also involved in the production of Chinese herbal medicine slices, ginseng and antler tonic, health products, Chinese and Western patent medicines. The firm's brands include Dong Zi Yun Xuan, Cocoking, Nobe Huale, Dongteng Ejiao, and Fuer. The firm mainly conducts business within domestic market.